Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Microbial bioconversion of thermally depolymerized polypropylene by Yarrowia lipolytica for fatty acid production.

Mihreteab M, Stubblefield BA, Gilbert ES.

Appl Microbiol Biotechnol. 2019 Sep;103(18):7729-7740. doi: 10.1007/s00253-019-09999-2. Epub 2019 Jul 31.

PMID:
31367856
2.

Rhamnus prinoides (gesho): A source of diverse anti-biofilm activity.

Campbell M, Zhao W, Fathi R, Mihreteab M, Gilbert ES.

J Ethnopharmacol. 2019 Sep 15;241:111955. doi: 10.1016/j.jep.2019.111955. Epub 2019 May 16.

PMID:
31102615
3.

Cataract risk in US radiologic technologists assisting with fluoroscopically guided interventional procedures: a retrospective cohort study.

Velazquez-Kronen R, Borrego D, Gilbert ES, Miller DL, Moysich KB, Freudenheim JL, Wactawski-Wende J, Cahoon EK, Little MP, Millen AE, Balter S, Alexander BH, Simon SL, Linet MS, Kitahara CM.

Occup Environ Med. 2019 May;76(5):317-325. doi: 10.1136/oemed-2018-105360. Epub 2019 Mar 19.

PMID:
30890565
4.

Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.

Linet MS, Gilbert ES, Vermeulen R, Dores GM, Yin SN, Portengen L, Hayes RB, Ji BT, Lan Q, Li GL, Rothman N; Chinese Center for Disease Control and Prevention–US National Cancer Institute Benzene Study Group .

J Natl Cancer Inst. 2019 May 1;111(5):465-474. doi: 10.1093/jnci/djy143.

PMID:
30520970
5.

Molecules and Mechanisms Underlying the Antimicrobial Activity of Escapin, an l-Amino Acid Oxidase from the Ink of Sea Hares.

Derby CD, Gilbert ES, Tai PC.

Biol Bull. 2018 Aug;235(1):52-61. doi: 10.1086/699175. Epub 2018 Jul 30.

PMID:
30160994
6.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.

Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.

Leukemia. 2018 Dec;32(12):2580-2589. doi: 10.1038/s41375-018-0149-2. Epub 2018 May 24.

PMID:
29795414
7.

Mortality in U.S. Physicians Likely to Perform Fluoroscopy-guided Interventional Procedures Compared with Psychiatrists, 1979 to 2008.

Linet MS, Kitahara CM, Ntowe E, Kleinerman RA, Gilbert ES, Naito N, Lipner RS, Miller DL, Berrington de Gonzalez A; Multi-Specialty Occupational Health Group.

Radiology. 2017 Aug;284(2):482-494. doi: 10.1148/radiol.2017161306. Epub 2017 Feb 23.

8.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

9.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

10.

Inhibition and Dispersal of Pseudomonas aeruginosa Biofilms by Combination Treatment with Escapin Intermediate Products and Hydrogen Peroxide.

Santiago AJ, Ahmed MN, Wang SL, Damera K, Wang B, Tai PC, Gilbert ES, Derby CD.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5554-62. doi: 10.1128/AAC.02984-15. Print 2016 Sep.

11.

A retrospective cohort study of cause-specific mortality and incidence of hematopoietic malignancies in Chinese benzene-exposed workers.

Linet MS, Yin SN, Gilbert ES, Dores GM, Hayes RB, Vermeulen R, Tian HY, Lan Q, Portengen L, Ji BT, Li GL, Rothman N; Chinese Center for Disease Control and Prevention-U.S. National Cancer Institute Benzene Study Group.

Int J Cancer. 2015 Nov 1;137(9):2184-97. doi: 10.1002/ijc.29591. Epub 2015 Jun 16.

12.

Increased stomach cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Fossa SD, Stovall M, van Leeuwen FE, Johannesen TB, Rajaraman P, Gilbert ES, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Travis LB, Morton LM.

Br J Cancer. 2015 Jan 6;112(1):44-51. doi: 10.1038/bjc.2014.552. Epub 2014 Nov 4.

13.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

14.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

Dores GM, Curtis RE, van Leeuwen FE, Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Fraumeni JF Jr, Aleman BM, Morton LM, Gilbert ES.

Ann Oncol. 2014 Oct;25(10):2073-9. doi: 10.1093/annonc/mdu287. Epub 2014 Jul 25.

15.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

Health Phys. 2014 Feb;106(2):229-46. doi: 10.1097/HP.0000000000000013. Review.

PMID:
24378498
16.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

17.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF Jr, Curtis RE.

Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.

18.

Lung cancer risks from plutonium: an updated analysis of data from the Mayak worker cohort.

Gilbert ES, Sokolnikov ME, Preston DL, Schonfeld SJ, Schadilov AE, Vasilenko EK, Koshurnikova NA.

Radiat Res. 2013 Mar;179(3):332-42. doi: 10.1667/RR3054.1. Epub 2013 Feb 7.

19.
20.

LuxS influences Escherichia coli biofilm formation through autoinducer-2-dependent and autoinducer-2-independent modalities.

Niu C, Robbins CM, Pittman KJ, Osborn jL, Stubblefield BA, Simmons RB, Gilbert ES.

FEMS Microbiol Ecol. 2013 Mar;83(3):778-91. doi: 10.1111/1574-6941.12034. Epub 2012 Nov 26.

21.

Risk of salivary gland cancer after childhood cancer: a report from the Childhood Cancer Survivor Study.

Boukheris H, Stovall M, Gilbert ES, Stratton KL, Smith SA, Weathers R, Hammond S, Mertens AC, Donaldson SS, Armstrong GT, Robison LL, Neglia JP, Inskip PD.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):776-83. doi: 10.1016/j.ijrobp.2012.06.006. Epub 2012 Jul 24.

22.

Cancer mortality following in utero exposure among offspring of female Mayak Worker Cohort members.

Schonfeld SJ, Tsareva YV, Preston DL, Okatenko PV, Gilbert ES, Ron E, Sokolnikov ME, Koshurnikova NA.

Radiat Res. 2012 Sep;178(3):160-5. Epub 2012 Jul 16.

23.

Risk of treatment-related esophageal cancer among breast cancer survivors.

Morton LM, Gilbert ES, Hall P, Andersson M, Joensuu H, Vaalavirta L, Dores GM, Stovall M, Holowaty EJ, Lynch CF, Curtis RE, Smith SA, Kleinerman RA, Kaijser M, Storm HH, Pukkala E, Weathers RE, Linet MS, Rajaraman P, Fraumeni JF Jr, Brown LM, van Leeuwen FE, Fossa SD, Johannesen TB, Langmark F, Lamart S, Travis LB, Aleman BM.

Ann Oncol. 2012 Dec;23(12):3081-91. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.

24.

Second malignant neoplasms and cardiovascular disease following radiotherapy.

Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, Purdy JA, Applegate K, Yahalom J, Constine LS, Gilbert ES, Boice JD Jr.

J Natl Cancer Inst. 2012 Mar 7;104(5):357-70. doi: 10.1093/jnci/djr533. Epub 2012 Feb 6. Review.

25.

How much can we say about site-specific cancer radiation risks?

Preston DL, Krestinina LY, Sokolnikov ME, Ron E, Davis FG, Ostroumova EV, Gilbert ES.

Radiat Res. 2010 Dec;174(6):816-24. doi: 10.1667/RR2024.1. Epub 2010 Sep 13.

PMID:
21128806
26.

Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update.

Gilbert ES, Huang L, Bouville A, Berg CD, Ron E.

Radiat Res. 2010 May;173(5):659-64. doi: 10.1667/RR2057.1.

27.

Constructing multispecies biofilms with defined compositions by sequential deposition of bacteria.

Stubblefield BA, Howery KE, Islam BN, Santiago AJ, Cardenas WE, Gilbert ES.

Appl Microbiol Biotechnol. 2010 May;86(6):1941-6. doi: 10.1007/s00253-010-2473-y. Epub 2010 Feb 24.

PMID:
20180119
28.

Agarose stabilization of fragile biofilms for quantitative structure analysis.

Pittman KJ, Robbins CM, Osborn JL, Stubblefield BA, Gilbert ES.

J Microbiol Methods. 2010 May;81(2):101-7. doi: 10.1016/j.mimet.2010.02.001. Epub 2010 Feb 10.

PMID:
20152866
29.

Comparison of second cancer risks from brachytherapy and external beam therapy after uterine corpus cancer.

Lönn S, Gilbert ES, Ron E, Smith SA, Stovall M, Curtis RE.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):464-74. doi: 10.1158/1055-9965.EPI-09-0892.

30.

Secondary malignancies across the age spectrum.

Ng AK, Kenney LB, Gilbert ES, Travis LB.

Semin Radiat Oncol. 2010 Jan;20(1):67-78. doi: 10.1016/j.semradonc.2009.09.002. Review.

31.

The impact of dosimetry uncertainties on dose-response analyses.

Gilbert ES.

Health Phys. 2009 Nov;97(5):487-92. doi: 10.1097/HP.0b013e3181adc3b1.

32.

Inhibition of quorum sensing in Vibrio harveyi by boronic acids.

Ni N, Choudhary G, Peng H, Li M, Chou HT, Lu CD, Gilbert ES, Wang B.

Chem Biol Drug Des. 2009 Jul;74(1):51-6. doi: 10.1111/j.1747-0285.2009.00834.x.

PMID:
19519744
33.

Ionising radiation and cancer risks: what have we learned from epidemiology?

Gilbert ES.

Int J Radiat Biol. 2009 Jun;85(6):467-82. doi: 10.1080/09553000902883836. Review.

34.

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

Landgren O, Gilbert ES, Rizzo JD, Socié G, Banks PM, Sobocinski KA, Horowitz MM, Jaffe ES, Kingma DW, Travis LB, Flowers ME, Martin PJ, Deeg HJ, Curtis RE.

Blood. 2009 May 14;113(20):4992-5001. doi: 10.1182/blood-2008-09-178046. Epub 2009 Mar 5.

35.

Second cancers after squamous cell carcinoma and adenocarcinoma of the cervix.

Chaturvedi AK, Kleinerman RA, Hildesheim A, Gilbert ES, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fossa SD, Joensuu H, Travis LB, Engels EA.

J Clin Oncol. 2009 Feb 20;27(6):967-73. doi: 10.1200/JCO.2008.18.4549. Epub 2008 Dec 29.

36.

Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers.

Kocher DC, Apostoaei AI, Henshaw RW, Hoffman FO, Schubauer-Berigan MK, Stancescu DO, Thomas BA, Trabalka JR, Gilbert ES, Land CE.

Health Phys. 2008 Jul;95(1):119-47. doi: 10.1097/01.HP.0000291191.49583.f7.

37.

Lung, liver and bone cancer mortality in Mayak workers.

Sokolnikov ME, Gilbert ES, Preston DL, Ron E, Shilnikova NS, Khokhryakov VV, Vasilenko EK, Koshurnikova NA.

Int J Cancer. 2008 Aug 15;123(4):905-11. doi: 10.1002/ijc.23581.

38.

Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.

Chaturvedi AK, Engels EA, Gilbert ES, Chen BE, Storm H, Lynch CF, Hall P, Langmark F, Pukkala E, Kaijser M, Andersson M, Fosså SD, Joensuu H, Boice JD, Kleinerman RA, Travis LB.

J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43. Epub 2007 Oct 30.

PMID:
17971527
39.

The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: study of errors in dosimetry.

Thierry-Chef I, Marshall M, Fix JJ, Bermann F, Gilbert ES, Hacker C, Heinmiller B, Murray W, Pearce MS, Utterback D, Bernar K, Deboodt P, Eklof M, Griciene B, Holan K, Hyvonen H, Kerekes A, Lee MC, Moser M, Pernicka F, Cardis E.

Radiat Res. 2007 Apr;167(4):380-95.

PMID:
17388692
40.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

Hodgson DC, Gilbert ES, Dores GM, Schonfeld SJ, Lynch CF, Storm H, Hall P, Langmark F, Pukkala E, Andersson M, Kaijser M, Joensuu H, Fosså SD, Travis LB.

J Clin Oncol. 2007 Apr 20;25(12):1489-97. Epub 2007 Mar 19.

PMID:
17372278
41.

Leukemia following breast cancer: an international population-based study of 376,825 women.

Howard RA, Gilbert ES, Chen BE, Hall P, Storm H, Pukkala E, Langmark F, Kaijser M, Andersson M, Joensuu H, Fossa SD, Travis LB.

Breast Cancer Res Treat. 2007 Nov;105(3):359-68. Epub 2007 Jan 13.

PMID:
17221155
42.

Enhanced high copy number plasmid maintenance and heterologous protein production in an Escherichia coli biofilm.

O'Connell HA, Niu C, Gilbert ES.

Biotechnol Bioeng. 2007 Jun 15;97(3):439-46.

PMID:
17058286
43.

Subinhibitory concentrations of cinnamaldehyde interfere with quorum sensing.

Niu C, Afre S, Gilbert ES.

Lett Appl Microbiol. 2006 Nov;43(5):489-94.

44.

Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm.

O'Connell HA, Kottkamp GS, Eppelbaum JL, Stubblefield BA, Gilbert SE, Gilbert ES.

Appl Environ Microbiol. 2006 Jul;72(7):5013-9.

45.

Some statistical implications of dose uncertainty in radiation dose-response analyses.

Schafer DW, Gilbert ES.

Radiat Res. 2006 Jul;166(1 Pt 2):303-12.

PMID:
16808615
46.

External dose estimation for nuclear worker studies.

Gilbert ES, Thierry-Chef I, Cardis E, Fix JJ, Marshall M.

Radiat Res. 2006 Jul;166(1 Pt 2):168-73.

PMID:
16808605
47.

Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident.

Cardis E, Krewski D, Boniol M, Drozdovitch V, Darby SC, Gilbert ES, Akiba S, Benichou J, Ferlay J, Gandini S, Hill C, Howe G, Kesminiene A, Moser M, Sanchez M, Storm H, Voisin L, Boyle P.

Int J Cancer. 2006 Sep 15;119(6):1224-35.

48.

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.

Schonfeld SJ, Gilbert ES, Dores GM, Lynch CF, Hodgson DC, Hall P, Storm H, Andersen A, Pukkala E, Holowaty E, Kaijser M, Andersson M, Joensuu H, Fosså SD, Allan JM, Travis LB.

J Natl Cancer Inst. 2006 Feb 1;98(3):215-8.

PMID:
16449681
49.

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD Jr, Dores GM, Gilbert ES.

J Natl Cancer Inst. 2005 Sep 21;97(18):1354-65.

PMID:
16174857
50.

Enhanced swarming of bacteria on agar plates containing the surfactant Tween 80.

Niu C, Graves JD, Mokuolu FO, Gilbert SE, Gilbert ES.

J Microbiol Methods. 2005 Jul;62(1):129-32.

PMID:
15823402

Supplemental Content

Loading ...
Support Center